Hansoh Pharmaceuticals GLP-1/GIP dual agonist HS-20094, targeting overweight or obesity, has also entered Phase II clinical trials
If itching or other side effects become problematic on semaglutide, PlexusDx also offers oral semaglutide ($289/mo), tirzepatide injection ($289/mo), dual-compound GLP-Squared options, and the microdose GLP-1 protocol ($129/mo), which many patients tolerate better during the initial phase
Look into weight loss programs
Some people get side effects, especially at the start
Given the relatively positive safety profile of GLP-1 RA with a reduction in weight and HbA 1c , without an increased risk of DKA, they are an appealing adjunctive therapy for people with type 1 diabetes
For people with type 2 diabetes and obesity, guidelines increasingly favor choosing GLP-1-based agents early in the treatment regimen, particularly when weight and cardiorenal risk are central goals